Edition:
United Kingdom

Leap Therapeutics Inc (LPTX.OQ)

LPTX.OQ on NASDAQ Stock Exchange Global Market

7.51USD
5:43pm BST
Change (% chg)

$-0.15 (-1.96%)
Prev Close
$7.66
Open
$7.62
Day's High
$7.64
Day's Low
$7.46
Volume
3,266
Avg. Vol
20,664
52-wk High
$10.25
52-wk Low
$4.94

Latest Key Developments (Source: Significant Developments)

Leap Therapeutics Announces Pricing Of $14 Mln Public Offering Of Common Stock
Friday, 23 Mar 2018 

March 23 (Reuters) - Leap Therapeutics Inc ::LEAP THERAPEUTICS ANNOUNCES PRICING OF $14 MILLION PUBLIC OFFERING OF COMMON STOCK.SAYS PUBLIC OFFERING OF 1.87 MILLION COMMON SHARES PRICED AT $7.50PER SHARE.  Full Article

Leap Therapeutics Announces Proposed Public Offering Of Common Stock
Thursday, 22 Mar 2018 

March 22 (Reuters) - Leap Therapeutics Inc ::LEAP THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.  Full Article

Leap Therapeutics Files For Mixed Shelf Of Up To $100 Mln
Friday, 2 Mar 2018 

March 2 (Reuters) - Leap Therapeutics Inc ::LEAP THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING ‍​.  Full Article

Leap Therapeutics Reports Qtrly Loss Per Share Of $0.65
Friday, 23 Feb 2018 

Feb 23 (Reuters) - Leap Therapeutics Inc ::LEAP THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND ANNOUNCES DATE OF ITS ANNUAL MEETING OF STOCKHOLDERS.LEAP THERAPEUTICS - QTRLY LOSS PER SHARE $0.65.  Full Article

Leap Therapeutics Files For Resale Of Up To 3.73 Mln Shares Of Co's Common Stock By Selling Stockholders
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Leap Therapeutics Inc ::LEAP THERAPEUTICS INC FILES FOR RESALE OF UP TO 3.73 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDERS - SEC FILING.  Full Article

Eli Lilly And Co reports 17.5 pct passive stake in Leap Therapeutics ‍​as of Nov 14
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Eli Lilly And Co :Eli Lilly And Co reports 17.5 percent passive stake in Leap Therapeutics Inc‍​ ‍​as of November 14 - SEC Filing.  Full Article

Leap Therapeutics announces $18 million private placement offering
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Leap Therapeutics Inc ::Announces $18 million private placement offering.Upon closing of transaction, leap will sell 2.96 million shares of unregistered common stock​.Signed voting agreement with HealthCare Ventures to vote shares in favor of approval proposed at stockholders​ special meeting.To sell shares in private placement with select institutional investors, strategic partners, including HealthCare Ventures, Eli Lilly.  Full Article

Leap Therapeutics qtrly loss per share $0.73
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Leap Therapeutics Inc -:Leap Therapeutics reports third quarter 2017 financial results and announces first patient dosed with DKN-01 and Keytruda® (pembrolizumab) in esophagogastric cancer trial.Leap Therapeutics Inc - ‍cash, cash equivalents and marketable securities totaled $14.2 million at September 30, 2017​.Leap Therapeutics Inc - ‍net loss was $6.8 million for Q3 of 2017, compared to $7.3 million for same period in 2016​.Leap therapeutics inc - qtrly loss per share $0.73.  Full Article

Leap Therapeutics announces collaboration with EORTC
Friday, 8 Sep 2017 

Sept 8 (Reuters) - Leap Therapeutics Inc :Leap Therapeutics announces collaboration with EORTC to evaluate DKN-01 in combination with PD-l1 cancer immunotherapy and chemotherapy in esophagogastric and biliary tract cancers.Leap Therapeutics Inc - ‍Roche will supply atezolizumab to EORTC for this study collaboration​.Leap Therapeutics Inc - ‍study is expected to begin enrolling patients in 2018​.Leap Therapeutics - ‍study aims to understand synergy between DKN-01, a WNT-targeted therapy, and immune checkpoint inhibitor with and without chemotherapy​.  Full Article

Leap Therapeutics says Q2 loss per share $0.74
Friday, 11 Aug 2017 

Aug 11 (Reuters) - Leap Therapeutics Inc :Q2 loss per share $0.74 - SEC filing.  Full Article

BRIEF-Leap Therapeutics Announces Pricing Of $14 Mln Public Offering Of Common Stock

* LEAP THERAPEUTICS ANNOUNCES PRICING OF $14 MILLION PUBLIC OFFERING OF COMMON STOCK